TODAY'S NEWS

NeoCOAST Durvalumab Monotherapy vs Combi...

The anti–PD-L1 monoclonal antibody durvalumab in c...

---

Modified Citrus Pectin Treatment for Non...

In the long-term treatment phase of an Israeli pha...

---

HERTHENA-Lung01 Patritumab Deruxtecan fo...

In the phase II HERTHENA-Lung01 trial reported in ...

---

The Immune System May Play Vital Role in...

Researchers have uncovered the vital role that the...

---

First-Line NALIRIFOX vs Nab-paclitaxel/G...

As reported in The Lancet by Zev A. Wainberg, MD, ...

More News From Today

EDITORIALS & COMMENTARY

Advanced Practitioners as Allies and Advocates

Advanced practitioners (APs) are a growing proportion of the health-care team...

---

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

---

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

---

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

---

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

---

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

---

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

---

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

---

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO Twitter Feed.cshtml)

More Tweets